Aier Eye Hospital Group Co., Ltd. (SHE:300015)
China flag China · Delayed Price · Currency is CNY
10.33
-0.28 (-2.64%)
At close: Feb 13, 2026

Aier Eye Hospital Group Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
22,09220,91020,31316,06914,97311,900
Other Revenue
72.8372.8354.341.1227.9112.34
22,16520,98320,36716,11015,00111,912
Revenue Growth (YoY)
7.49%3.02%26.43%7.39%25.93%19.24%
Cost of Revenue
11,77110,88710,0227,9817,2125,835
Gross Profit
10,39510,09610,3458,1297,7886,077
Selling, General & Admin
5,2785,1434,6383,8513,4062,493
Research & Development
310.24317.98331.32269.9221.18163.2
Other Operating Expenses
159.6363.3745.6544.6241.3228.32
Operating Expenses
5,9525,6415,1224,2433,7662,775
Operating Income
4,4434,4555,2233,8874,0223,302
Interest Expense
-274.64-255.56-194.82-177.65-164.66-75.38
Interest & Investment Income
161.42309.27165.73131.56199.53197.89
Currency Exchange Gain (Loss)
-10.34-10.3452.41128.9742.88-21.32
Other Non Operating Income (Expenses)
100.54-40.24-54.19-38.19-44.93-35.99
EBT Excluding Unusual Items
4,4204,4585,1923,9314,0553,367
Impairment of Goodwill
-187.7-187.7-383.61-95.34-216.66-361.52
Gain (Loss) on Sale of Investments
140.98334.4-79.42-356.89-448.39-380.41
Gain (Loss) on Sale of Assets
0.534.270.71-1.250.050.93
Asset Writedown
-6.92-6.82-6.11-5.01-4.27-4.41
Other Unusual Items
-80.55-8.24-172.76-137.88-237.77-258.79
Pretax Income
4,2864,5944,5513,3353,1482,363
Income Tax Expense
850.9858.15895.02646.06677.85486.11
Earnings From Continuing Operations
3,4353,7363,6562,6892,4701,877
Minority Interest in Earnings
-216.04-180.07-297.12-164.77-146.56-153.36
Net Income
3,2193,5563,3592,5242,3231,724
Net Income to Common
3,2193,5563,3592,5242,3231,724
Net Income Growth
-11.31%5.87%33.06%8.65%34.78%25.01%
Shares Outstanding (Basic)
9,2659,2449,2189,0479,0548,922
Shares Outstanding (Diluted)
9,2659,2449,2519,0609,0548,922
Shares Change (YoY)
-0.01%-0.07%2.10%0.07%1.48%1.39%
EPS (Basic)
0.350.380.360.280.260.19
EPS (Diluted)
0.350.380.360.280.260.19
EPS Growth
-11.30%5.95%30.33%8.57%32.82%23.29%
Free Cash Flow
4,0063,0524,4123,1022,5902,450
Free Cash Flow Per Share
0.430.330.480.340.290.28
Dividend Per Share
0.2400.1600.1500.0770.0710.069
Dividend Growth
59.98%6.65%95.09%8.31%3.65%29.98%
Gross Margin
46.90%48.12%50.79%50.46%51.92%51.02%
Operating Margin
20.04%21.23%25.64%24.13%26.81%27.72%
Profit Margin
14.52%16.95%16.49%15.67%15.49%14.47%
Free Cash Flow Margin
18.07%14.54%21.66%19.26%17.27%20.57%
EBITDA
5,3635,2765,9114,5074,5113,718
EBITDA Margin
24.20%25.14%29.02%27.97%30.07%31.21%
D&A For EBITDA
920.61820.8687.72619.79489.23415.92
EBIT
4,4434,4555,2233,8874,0223,302
EBIT Margin
20.04%21.23%25.64%24.13%26.81%27.72%
Effective Tax Rate
19.85%18.68%19.67%19.37%21.53%20.57%
Revenue as Reported
22,16520,98320,36716,11015,00111,912
Advertising Expenses
-987.95937.29723.56--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.